Tenaya Therapeutics Announces Research Leadership Updates
Tenaya Therapeutics, Inc. (TNYA)
Company Research
Source: GlobeNewswire
Kathy Ivey, Ph.D., Promoted to Senior Vice President, Research and Timothy Hoey, Ph.D., Transitions to Advisory Role Pediatric Cardiologist and Genetic Therapy Expert Barry J. Byrne, M.D., Ph.D., Joins Scientific Advisory Board Board Member Jin-Long Chen, Ph.D., Steps Down SOUTH SAN FRANCISCO, Calif., June 27, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced changes to its Research leadership team, including new appointments to the company’s Scientific Advisory Board (SAB). Kathy Ivey, Ph.D., Vice President of Gene Therapy Research, will be promoted to Senior Vice President, Research, with responsibility for all Tenaya’s non-clinical research and discovery work. Timothy Hoey, Ph.D., who has served as Tenaya’s Chief Scientific Officer since 2017, will step down from his role. Dr
Show less
Read more
Impact Snapshot
Event Time:
TNYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNYA alerts
High impacting Tenaya Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TNYA
News
- Tenaya Therapeutics Announces Research Leadership Updates [Yahoo! Finance]Yahoo! Finance
- Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA SummitGlobeNewswire
- Tenaya Therapeutics, Inc. (NASDAQ: TNYA) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.MarketBeat
- We're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate [Yahoo! Finance]Yahoo! Finance
- Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
TNYA
Earnings
- 5/14/24 - Beat
TNYA
Sec Filings
- 6/27/24 - Form 8-K
- 5/31/24 - Form 8-K
- 5/14/24 - Form 10-Q
- TNYA's page on the SEC website